Filing Details

Accession Number:
0001209191-24-001875
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-18 20:24:29
Reporting Period:
2024-01-18
Accepted Time:
2024-01-18 20:24:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505512 Regulus Therapeutics Inc. RGLS Pharmaceutical Preparations (2834) 264738379
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1606833 Crispina Calsada C/O Regulus Therapeutics
4224 Campus Point Court #210
San Diego CA 92121
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-18 5,468 $1.19 5,782 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares of common stock to cover tax withholding obligations incurred in connection with the vesting of the restricted stock unit award received by the Reporting Person on 1/11/2023.